Tripping up addiction: the use of psychedelic drugs in the treatment of problematic drug and alcohol use
Authors:
- Celia MorganCMCelia Morgan
- Amy McAndrewAMAmy McAndrew
- Tobias StevensTSTobias Stevens
- David NuttDNDavid Nutt
- Will LawnWLWill Lawn
- 1 February 2017
- journal article
- Published by Elsevier in Current Opinion in Behavioral Sciences
- Vol. 13, 71-76
Abstract
No abstract availableFunding Information
- Medical Research CouncilMedical Research Council (MRC) (MR/L023032/1)
- Beckley Foundation
This publication has 48 references indexed in Scilit:
- Neural correlates of the LSD experience revealed by multimodal neuroimagingProceedings of the National Academy of Sciences, 2016
- Classic hallucinogens in the treatment of addictionsProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2016
- Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept studyJournal of Psychopharmacology, 2015
- Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addictionJournal of Psychopharmacology, 2014
- Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trialsJournal of Psychopharmacology, 2012
- ‘Hitting Highs at Rock Bottom’: LSD Treatment for Alcoholism, 1950–1970Social History of Medicine, 2006
- HallucinogensPharmacology & Therapeutics, 2004
- Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist actionNeuroReport, 1998
- Treatment of Alcoholism Using Psychedelic Drugs: A Review of the Program of ResearchJournal of Psychoactive Drugs, 1998
- Residential Psychedelic (LSD) Therapy for the Narcotic AddictArchives of General Psychiatry, 1973